|
Volumn 26, Issue 3 SUPPL. 11, 1999, Pages 28-31
|
Docetaxel (Taxotere) administered in weekly schedules
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
ADULT;
AGED;
ARTICLE;
ASTHENIA;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDEMA;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALE;
MAXIMUM PERMISSIBLE DOSE;
METASTASIS;
NEUROPATHY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
EID: 0032818024
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (53)
|
References (13)
|